S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia
Oct 16, 2023
12:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.
OncLive® On Air